OBJECTIVE This project aimed to increase continuous glucose monitor (CGM) adoption and use among pediatric and adolescent patients with type 1 diabetes at the University of Michigan while reducing racial and ethnic disparities. RESEARCH DESIGN AND METHODS We conducted a quality-improvement (QI) project from February 2022 through December 2023. Over the project period, several interventions were tested through Plan-Do-Study-Act cycles, including patient-facing CGM education, implementation of revised electronic health record (EHR) flowsheets to track CGM adoption and use, as well as address barriers, prescribing-related workflow changes, and provision of technical support to newly diagnosed patients starting a CGM. CGM adoption and use rates were measured and stratified by race and ethnicity. RESULTS At baseline, 87% of non-Hispanic White (NHW) patients and 75% of non-White patients had a CGM. By June 2024, adoption rates increased to 98% for NHW patients and 97% for non-White patients. CGM use (70% of the time) also improved, reaching 89% among NHW and 88% among non-White patients. CONCLUSIONS This initiative demonstrates that QI interventions, including efforts to address individual-level barriers, can substantially increase CGM adoption and use while improving equity. The findings highlight the importance of standardizing clinic workflows and patient engagement in advancing diabetes technology adoption.
GARRITY et al. (2026) studied this question.